Skip to main content

Table 5 The risk factors for chemotherapy-associated lymphopenia <0.91 × 10 9 /L in colorectal cancer by multivariate logistic regression model

From: The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer

Variables Odds ratio 95% confidence intervals P-value
Pretreatment albumin    
≥35 g/L 1.00(ref.)   
<35 g/L 1.410 0.772-2.576 0.263
Pretreatment CEA a    
<10 ng ml-1 1.00(ref.)   
≥10 ng ml-1 1.885 0.984-3.610 0.056
Differentiation    
Well 1.00(ref.)   
Moderately 1.590 0.564-4.483 0.381
Low 2.694 0.694-10.458 0.152
Sex    
Male 1.00(ref.)   
Female 1.725 0.987-3.016 0.056
Age    
≤49 years 1.00(ref.)   
50-60 yeas 1.617 0.705-3.709 0.256
>60 years 2.872 1.344-6.136 0.006
Location    
Rectum 1.00(ref.)   
Left colon cancer 0.948 0.502-1.789 0.869
Right colon cancer 0.780 0.381-1.596 0.496
Stage    
II 1.00(ref.)   
III 0.881 0.494-1.572 0.668
  1. a Carcinoembryonic antigen.